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Abstract 
Background: The classification of natural antimicrobials as potential antibiotic replacements is still hampered by the 
absence of clear biological mechanisms behind their mode of action. This study investigated the mechanisms under‑
lying the anti‑bacterial effect of a mixture of natural antimicrobials (maltodextrin, citric acid, sodium citrate, malic 
acid, citrus extract and olive extract) against Campylobacter jejuni RC039, Salmonella enterica SE 10/72 and Clostridium 
perfringens ATCC® 13124 invasion of Madin–Darby Canine Kidney cells (MDCK).
Results: Minimum sub‑inhibitory concentrations were determined for Campylobacter jejuni (0.25%), Salmonella 
enterica (0.50%) and Clostridium perfringens (0.50%) required for the in vitro infection assays with MDCK cells. The 
antimicrobial mixture significantly reduced the virulence of all three pathogens towards MDCK cells and restored the 
integrity of cellular tight junctions through increased transepithelial resistance (TEER) and higher expression levels 
of ZO‑1 (zonula occludens 1) and occludin. This study also identified the ERK (external regulated kinase) signalling 
pathway as a key mechanism in blocking the pro‑inflammatory cytokine production (IL‑1β, IL‑6, IL‑8, TNF‑α) in infected 
cells. The reduction in hydrogen peroxide  (H2O2) production and release by infected MDCK cells, in the presence of 
the antimicrobial mixture, was also associated with less tetrathionate formed by oxidation of thiosulphate (p < 0.0001).
Conclusion: The present study describes for the first time that mixtures of natural antimicrobials can prevent the for‑
mation of substrates used by bacterial pathogens to grow and survive in anaerobic environments (e.g. tetrathionate). 
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Background
Food-borne bacterial illnesses affect approximately 226 
million people each year [1, 2]. Infections caused by food-
borne zoonotic agents, such as Campylobacter spp., Sal-
monella spp., and Clostridium spp., are associated with 
high morbidity rates worldwide in both humans and ani-
mals [3]. Household pets can also contract these patho-
gens through non-food sources, such as the environment, 
pet feed and contact with infected animals or humans [4].
Poultry meat is considered the main source of Campy-
lobacter for human infections, however, the presence of 
this bacterium in dogs and cats increases significant pub-
lic health concerns as pets can potentially be considered 
a transmission vector [5]. In dogs, Campylobacter spp. 
infection can trigger acute polyradiculoneuritis (APN), a 
canine version of Guillen-Barre Syndrome (GBS) which 
displays similar pathologies [6]. In companion animals, 
salmonellosis is mainly caused by Salmonella enterica 
serovar Typhimurium and specifically, in dogs is trans-
mitted via the consumption of raw feeds rather than pro-
cessed feeds [7]. Following infection, the bacterium is 
primarily isolated from the mesenteric lymph nodes and 
intestinal tracts. Dogs can be asymptomatic carriers for 
more than 42  days, during which time the pathogen is 
easily transmissible to humans [8]. Clostridium perfrin-
gens is mainly associated with acute haemorrhagic diar-
rhoea syndrome (AHDS) in dogs [9]. Symptoms normally 
are a mild or self-limiting diarrhoea, but in some cases 
can also lead to fatal acute haemorrhagic diarrhoea. In 
cases of severe haemorrhagic canine gastroenteritis,a 
severe necrotising inflammation of the intestinal tract 
epithelium can occur which can lead to rapid mortality 
[10].
Mixtures of natural antimicrobials (e.g. plant extracts 
or organic acids) have been shown to prevent colonisa-
tion or infection of the epithelium in a variety of hosts, 
including ruminants, monogastrics and aquatic crusta-
ceans [11–16]. The anti-infective mode of action occurs 
by improving the host gastrointestinal epithelium integ-
rity and downregulating some of the vital bacterial viru-
lence factors (e.g. motility, bacterial polysaccharides). 
At the host level, the antimicrobial mode of action was 
related to the restoration of tight junction (TJ) integrity, 
and diminished inflammation via a reduction in pro-
inflammatory cytokine secretion throughout the gut [15]. 
Common canine pathogens (e.g., Campylobacter spp., 
Salmonella spp., and Clostridium spp.) are inhibited by 
mixtures of these natural antimicrobials [17, 18].
Understanding the biological mechanism by which 
natural antimicrobials reduce bacterial infections and 
reduce epithelial inflammation is essential to establish 
best practices for end users, and ensure that their specific 
anti-bacterial effect can be consistently utilized. Bacte-
rial pathogens, including Campylobacter, can disrupt 
epithelial tight junctions (TJ) upon infection [19] and 
will stimulate the host NADPH oxidases to produce and 
release extra and intra-cellular hydrogen peroxide  (H2O2) 
[20]. At the cytoplasmic level, consequences of  H2O2 pro-
duction include the activation of the extracellular signal-
regulated kinase (ERK), which is central to the signalling 
cascade leading to pro-inflammatory cytokine produc-
tion [21, 22]. The involvement of the ERK pathways in 
pro-inflammatory events was previously described [23] 
as being closely related to bacterial infection [24]. Other 
natural antimicrobial extracts (e.g., ambuic acid) have 
an anti-inflammatory action that blocks activation of 
the ERK signalling pathway in lipopolysaccharide (LPS)-
treated cells [25].
Natural antimicrobials can serve as both treatment 
and prophylaxis by preventing a drop in trans-epithelial 
resistance and restoring cellular TJ integrity [26]. The 
present study investigated the possible role of natural 
antimicrobials and their anti-pathogenic effect against 
C. jejuni RC039, S. enterica SE 10/72 and C. perfringens 
ATCC® 13124 in canine derived Madin–Darby Canine 
Kidney cells (MDCK). Further, we hypothesized that 
natural antimicrobials could prevent bacterially-induced 
oxidative stress and restore cellular structure integrity 
(including TJ or ZO-1 and occludin) damaged as a result 
of cytoplasmic  H2O2 release, and could block ERK acti-
vation and prevent inflammation and pro-inflammatory 
cytokine release. It is clear now that attenuation of ROS 
induced oxidative stress induced by the antimicrobial 
mixture also led to a decrease in host-induced molecules 
(e.g. tetrathionate) a well-known electron acceptor used 




First we aimed to establish the anti-pathogenic effect 
of a natural antimicrobial mixture (Auraguard) and 
Moreover, we provide further insights into pathogen invasion mechanisms through restoration of cellular structures 
and describe their ability to block the ERK–MAPK kinase pathway responsible for inflammatory cytokine release
Keywords: C. jejuni, S. enterica, C. perfringens, Natural antimicrobials, Hydrogen peroxide, ERK kinase, MDCK cells, 
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to determine the sub-inhibitory concentrations for C. 
jejuni, S. enterica and C. perfringens. Strong antimi-
crobial activity was detected against all three species 
(Fig.  1). The minimum inhibitory concentrations were 
0.25% for C. jejuni, and 0.50% for S. enterica and C. 
perfringens. The minimum bactericidal concentrations 
were noted at 0.50% for C. jejuni, at 1% for S. enterica 
and C. perfringens (Table 1). Based on these results we 
used concentrations of 0.25% for C. jejuni, and 0.5% for 
S. enterica and C. perfringens to test their inhibitory 
effect in preventing the infection of MDCK cells.
Fig. 1 Representative Petri plate images showing the inhibitory zones at different concentrations of Auraguard against C. jejuni (A), S. enterica (B) 
and C. perfringens (C)
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Auraguard prevents the in vitro infection of MDCK cells 
by C. jejuni, S. enterica and C. perfringens
In vitro infection assays were performed to identify if 
there was a direct effect on cellular invasion by Aura-
guard added at 0.25% and 0.50%. Exposure of MDCK 
cells prior to infection reduced (p = 0.03) the invasion of 
C. jejuni at concentrations of only 0.25% (Fig. 2B) with no 
significant decrease in adhesion (Fig. 2A). In the case of 
S. enterica there was a impact on both adhesion (Fig. 2C, 
p < 0.0001) and invasion (Fig.  2D, p = 0.0001) after pre-
treatment of MDCK cells with 0.50% Auraguard. A simi-
lar pattern was observed in C. perfringens infections with 
impacts on both bacterial adhesion (Fig. 2E, p = 0.02) and 
cell invasion (Fig. 2F, p = 0.004), when 0.50% Auraguard 
was used to pre-treat the epithelial cells. Overall, results 
suggest that Auraguard prevented the adhesion and inva-
sion of MDCK cells potentially by restoring the integrity 
of the cellular structures damaged by bacterial infection.
The effect of Auraguard on paracellular permeability, TEER, 
ZO‑1 and occludin expression in infected MDCK cells
Following the in vitro infection assay results we inves-
tigated the impact of Auraguard on cell membrane res-
toration leading to reduced infectivity. Treatment of 
MDCK cells with 0.25% and 0.5% Auraguard decreased 
the paracellular calcein flux indicating improvements 
(****p < 0.0001) in cellular membrane integrity (Fig. 3A). 
We expected that an improvement in membrane per-
meability should be accompanied by an improvement 
of cellular tight junctions quantified by measuring the 
trans-epithelial resistance. Our results show that infec-
tion of MDCK cells with C. jejuni, S. enterica and C. 
perfringens decreased the trans-epithelial resistance 
of cell monolayers at 3  h post-infection (Fig.  3B). In 
contrast, Auraguard exposure of cells led to increased 
TEER values reducing the detrimental effect of patho-
gen infection (p < 0.0001). To further prove that Aura-
guard has a beneficial impact on cellular membrane 
structures we measured the effect on the mRNA lev-
els of ZO-1 (Fig.  3C) and occludin (Fig.  3D). Results 
demonstrate that following infection with C. jejuni the 
addition of 0.25% Auraguard increased the expression 
of ZO-1 (p = 0.003) and occludin (p = 0.006) in cells. 
Similarly, an increase in ZO-1 and occluding expression 
(p = 0.0005 and p = 0.0002, respectively) occurred when 
MDCK cells were infected with S. enterica and exposed 
to 0.5% Auraguard. Infections with C. perfringens of 
MDCK cells pre-treated with 0.5% Auraguard also led 
to a significant increase in ZO-1 expression (p < 0.0001) 
and occludin (p < 0.0001). Collectively, these results 
suggest that Auraguard has a positive and restorative 
impact on cellular membrane integrity and prevents 
infection of epithelial cells.
Table 1 Minimum inhibitory concentration (MIC) and minimum 
bactericidal concentration (MBC) activity of the antimicrobial 
mixture
Strains MIC (%) MBC (%)
Campylobacter jejuni (RC039) 0.25 0.50
Salmonella enterica (SE10/72) 0.50 1
Clostridium perfringens (ATCC® 13124™) 0.50 1
Fig. 2 In vitro adhesion and invasion of Auraguard pre‑treated 
(0.25% and 0.50%) MDCK cells by C. jejuni RC039 (A—adhesion, B—
invasion), S. enterica (C—adhesion, D—invasion) and C. perfringens 
(E—adhesion, F—invasion). Results are expressed as CFU/ml. Error 
bars represent the standard deviation of means from three different 
experiments, each containing triplicate samples
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Auraguard blocks the ERK signal transduction pathway, 
prevents inflammation and the intra and extracellular  H2O2 
release in in MDCK cells but not bacterial invasion
Following the initial results indicating that Auraguard 
was involved in membrane restoration, we investigated 
if the ERK signalling pathway was involved in membrane 
restoration of infected MDCK cells. Infection of non-
Auraguard treated MDCK cells with C. jejuni (Fig.  4A) 
led to ≈ 25 nmol  H2O2 being secreted in the extracellu-
lar space (released  H2O2) compared with ≈ 8 nmol  H2O2 
(p = 0.0002) in cells pre-treated with 0.25% Auraguard, 
which was similar to uninfected controls (Fig. 4A). Infec-
tions with S. enterica generated ≈ 43 nmol  H2O2 which 
were reduced to ≈ 12  nmol  H2O2 (p < 0.0001) in Aura-
guard pre-treated cells (Fig.  4A). Similarly, infections 
with C. perfringens (Fig.  4A) led to a decrease in  H2O2 
concentrations from 35 nmol  H2O2 to 14 nmol  H2O2 in 
the presence of 0.50% Auraguard (p = 0.0003). Auraguard 
treatment also led to significant decrease in intracellular 
 H2O2 (p < 0.0001) (Fig. 4B). The presence of the ERK sig-
nal transduction pathway inhibitor (PD98059) also led to 
decrease in  H2O2 both extra and intracellularly (Fig. 4A, 
B). The unavailability of  H2O2 caused the restoration of 
TEER when cells were exposed to Auraguard or PD98059 
(Fig.  4C), significantly decreased paracellular perme-
ability (Fig.  4D) and restored the expression of ZO-1 
(Fig. 4E). Our results also suggest that the antimicrobial 
mixture reduces bacterial invasion and diminishes post-
infection pro-inflammatory events (Fig. 4F).
The IL‑1β, IL‑6, IL‑8, TNF‑α levels are attenuated in infected 
MDCK cells by Auraguard via the ERK signal transduction 
pathway
In order to further examine anti-inflammatory impacts of 
Auraguard we measured IL-1β, IL-6, IL-8, TNF-α secre-
tion by infected MDCK cells. Cells were infected with 
C. jejuni, S. enterica and C. perfringens and ERK stimu-
lation was assessed in cells treated at 0.25% and 0.50% 
Auraguard during pathogen infection using Western 
blot. Bacterial infection primed activation of the ERK 
MAP kinase, but was inhibited by Auraguard at 3 h fol-
lowing infection (Fig. 5). Our investigation into the role 
of the ERK signal transduction pathway as the mechanis-
tic tool in reducing the inflammatory effect of bacterial 
invasion by Auraguard indicated that the modulation of 
pro-inflammatory gene expression in the MDCK cells 
was restored to un-infected levels by the pre-treatment 
with Auraguard and the ERK inhibitor PD98059. Under 
Fig. 3 The effect of Auraguard on infected MDCK cells paracellular membranes calcein flux (A), TEER (B), ZO‑1 (C) and occluding expression (D) 
during infection with C. jejuni, S. enterica or C. perfringens. Data are presented as means (SD) of triplicate independent samples and experiments
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inflammatory conditions, there was an increased activa-
tion of IL-1β, IL-6, IL-8, TNF-α in MDCK cells follow-
ing infection with C. jejuni RC039 (Fig.  6A), S. enterica 
(Fig. 6B) and C. perfringens (Fig. 6C). Cytokine levels in 
un-infected cells were below the detection limit (data not 
shown). However, our results indicate that pre-treatment 
with Auraguard at levels of 0.25% for C. jejuni (Fig. 6A) 
and 0.50% for S. enterica (Fig.  6B) and C. perfringens 
(Fig.  6C) reduced levels of IL-1β, IL-6, IL-8, TNF-α. 
Reduced inflammation was also observed when cells 
were pre-treated with the ERK inhibitor PD98059. Firstly, 
these results show that Auraguard reduced epithelial 
inflammation as indicated by the cytokine detection lev-
els and secondly, inhibits the ERK signal transduction 
Fig. 4 The effect of Auraguard and the ERK inhibitor PD98059 on infected MDCK cells. The extracellular levels of  H2O2 released by the infected 
MDCK cells and Auraguard and PD98509 treated MDCK cells are presented in panel A and the intra‑cellular levels in panel B. Panel C shows the 
effect on MDCK cells TEER with panel D describing the effect on paracellular permeability and in panel E the ZO‑1 expression levels. The bacterial 
infectivity levels are shown in panel F. The significance levels are indicated on the graph. Data are presented as means (SD) of triplicate independent 
samples and experiments
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pathway in cultured MDCK cells. Overall, these results 
demonstrate that bacterial infections can activate MAP 
kinase pathways in cultured MDCK cells and launch pro-
inflammatory events, a mechanism which is independent 
from bacterial internalization.
Antimicrobial reduced inflammation results in reduction 
in tetrathionate production
Treatment with the antimicrobial mixture caused a 
reduction in cell released reactive oxygen species (ROS) 
as well as inflammatory cytokine release in infected 
MDCK cells. This observation suggested that an impact 
on host driven molecules (e.g. tetrathionate) that sup-
port the growth and survival of bacterial pathogens in the 
gut, was also observed. The addition of 10  mM sodium 
thiosulfate during infection in vitro led to its conversion 
to tetrathionate in the supernatants of infected MDCK 
cells (Fig.  7). However, Auraguard inclusion decreased 
the levels of tetrathionate detected from 1 to 0.04  mM 
(p < 0.0001) in C. jejuni infected MDCK cell superna-
tants, from 2.8 to 0.3 mM in S. enterica infected MDCK 
cell supernatants (p < 0.0001) and from 0.58 to 0.025 mM 
in C. perfringens infected MDCK cells (p < 0.0001). These 
results indicate that in addition to the impacts of Aura-
guard on the extracellular and intracellular release of 
ROS, likely also causing a decrease in secondary mol-
ecules produced by the host during inflammation which 
are used as electron acceptors by bacteria in oxygen 
depleted environments.
Discussion
Understanding the biological mechanisms of how 
natural antimicrobials prevent infection and subse-
quent inflammation is limited. In certain pathogens 
Fig. 5 Inactivation of ERK kinases during C. jejuni, S. enterica and C. 
perfringens infection of MDCK cells by Auraguard. Activation of ERK 
was examined by Western immunoblot using monoclonal antibodies 
specific to the phosphorylated ERK kinase. Equal amounts of protein 
were added in each lane. Data were standardized on the basis of 
β‑actin levels. The Student’s t‑test was used to statistically compare 
the effect of Auraguard. p values are indicated on the graph
Fig. 6 Modulation of pro‑inflammatory genes expression (IL‑1β, IL‑6, 
IL‑8, TNF‑α) in infected MDCK cells pre‑exposed to 0.25% and 0.5% 
Auraguard or 30 µM of PD98059. Data are expressed as  2−DDCt where 
DCt = Ct (target gene) − Ct (housekeeping); values are the mean of 
three test replicates. Negative samples were given a Ct 38 fictitious 
value. The Student’s t‑test was used to statistically compare the effect 
of Auraguard. p values are indicated on the graph
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(e.g. Campylobacter jejuni) the mechanism of epithelial 
cell invasion is mechanistically separated from cellu-
lar inflammation [22], involving the extracellular signal 
transduction pathway (ERK) as an activation switch. 
ERKs are activated by bacteria through a mechanism 
involving posttranslational modifications through 
tyrosine phosphorylation leading to pro-inflammatory 
cytokine production [28]. Natural antimicrobials have 
previously been shown to have the ability to block ERK 
activation and prevent bacterial-induced inflammation 
[25].
Bacterial pathogens including C. jejuni, S. enterica and 
C. perfringens are known for their ability to disrupt epi-
thelial barriers and stimulate epithelial production and 
release of  H2O2 in both the intracellular and extracel-
lular spaces [20, 29]. Infection of MDCK cells with C. 
jejuni, S. enterica or C. perfringens generated an increase 
in  H2O2 detected in the intracellular and extracellular 
spaces. In MDCK cells the increase in  H2O2 production 
was associated with enhanced paracellular permeabil-
ity involving the disruption of ZO-1 protein within the 
actin cytoskeleton [30, 31]. It has been suggested that 
the molecular mechanisms controlling and modulat-
ing the paracellular permeability required the involve-
ment of occludin and ZO-1 proteins [32, 33]. Inclusion 
of Auraguard in all infections by C. jejuni, S. enterica 
and C. perfringens reduced membrane permeability, 
increased ZO-1 expression in MDCK cells and reduced 
 H2O2 production. All these events were followed by 
reduced invasive abilities of C. jejuni, S. enterica and C. 
perfringens in these in vitro cell lines. Organic acids (e.g. 
citrus extracts) have been shown to reduce the genera-
tion of reactive oxygen species thereby preventing oxida-
tive cell injury [34] and when used in combinations will 
restore TEER and improve cellular tight junctions [26]. 
The Auraguard-catalysed reduction in  H2O2 released 
by the infected MDCK cells was linked to the observed 
increased expression of the ZO-1 protein. The higher lev-
els of  H2O2 reduced occludin and ZO-1 protein content 
and their involvement in regulating the paracellular per-
meability [35, 36].
It remains unknown how tight junction structures 
are affected by endogenous  H2O2 production and how 
natural antimicrobials (e.g. organic acids) impact these 
structures. Extracellular signal-regulated kinases (ERKs) 
mediate tight junction disruption, and this mediation 
takes place in the cytoplasm being restrictively activated 
by  H2O2 [21, 37]. Secondly, from a prokaryotic perspec-
tive,  H2O2 activates the ERK signal transduction pathway 
triggering production of pro-inflammatory cytokines 
in infected intestinal cells [22, 38–40]. Thirdly, organic 
acids (e.g. Ambuic acid) exert anti-inflammatory effects 
by blocking the ERK signalling pathway [41]. In this study 
Auraguard blocked the  H2O2 activated ERK signalling 
pathway, prevented inflammation and averted the dam-
aging effect on tight junction structures. However, inhi-
bition of the ERK signalling pathway did not prevent 
invasion of MDCK cells by C. jejuni, S. enterica and C. 
perfringens suggesting that the anti-inflammatory mecha-
nism of Auraguard was disconnected from the anti-inva-
sive mechanism. Our study clearly demonstrates that the 
phospho-deactivation of ERK by Auraguard did not stop 
bacterial invasion, but did reduce subsequent inflam-
mation. Decoupling of invasion from inflammation was 
previously described by Campylobacter jejuni where epi-
thelial cell invasion was not necessary to initiate the pro-
inflammatory cascade [22]. Reduction in inflammatory 
cytokines was associated with increased TEER values, 
ZO-1 expression, and occludin expression suggesting 
that these cytokines could modulate tight junction integ-
rity and reduce cellular permeability. Specifically, it has 
been suggested that downstream effectors of MAP kinase 
Fig. 7 Tetrathionate levels determined by reverse phase LC–MS from supernatants of infected MDCK cells in the presence of sodium thiosulphate. 
A C. jejuni, B S. enterica and C C. perfringens. Data represent the mean ± SEM from three individual experiments
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signalling pathways mediate a reorganization of cellular 
barrier function via TNF-α [42]. The cytokine mediation 
likely coordinates the functions of caveolin-1, involved in 
cholesterol-rich membrane microdomains [32].
Inflammation of the host epithelium enhances the 
ability of some bacterial pathogens to grow and survive. 
Salmonella, similar to other pathogens [20], triggers the 
production of reactive oxygen species by neutrophils 
which oxidise thiosulphate into tetrathionate, a product 
used by Salmonella Typhimurium [43], Yersinia entero-
colitica [44] and Campylobacter jejuni [45] to grow in 
anaerobic conditions. In  vivo thiosulphate is produced 
through oxidation of  H2S by the colonic epithelium and 
further oxidised tetrathionate by commensal bacteria. 
Along with our observation of the reduction in intra and 
extracellular  H2O2 release, we also detected a reduction 
in tetrathionate production as a result of Auraguard-cat-
alyzed inhibition of  H2O2 production. Our results indi-
cate, that in  vivo, Auraguard could potentially reduce 
epithelial inflammation and also prevent the supply of 
host molecules (e.g. tetrathionate) that could promote 
the growth and survival of bacterial pathogens in oxygen-
depleted environments.
Conclusion
In previous studies we have shown that mixtures of natu-
ral antimicrobials are able to reduce bacterial virulence 
and improve the host defence mechanisms using both 
in vitro and in vivo infection models [11–13, 15, 16, 46]. 
The current study elucidates the biological mechanism 
that underlies the anti-pathogenic and anti-inflammatory 
effects of Auraguard, a mixture of natural antimicrobials. 
We found that this type of natural antimicrobial mixtures 
inhibited bacterial internalisation through the restoration 
of epithelial structures damaged by invasion. Secondly, 
they act via an anti-inflammatory mechanism involving 
the deactivation of the ERK signalling pathway through 
de-phosphorylation. We also show that these mecha-
nisms are similar across pathogenic species as the effects 
were observed in the case of C. jejuni, S. enterica and C. 
perfringens infections. Possible synergistic mechanisms 
and interactions between individual components indi-
cate the need for further in vivo investigations are needed 
to extrapolate these results to animal disease models 
and possibly to compare their effects to those of various 
antibiotics.
Material and methods
Bacterial strains and the mixture of natural antimicrobials
Campylobacter jejuni RC039 [47], Salmonella enterica 
serovar Typhimurium SE10/72 [48], including Clostrid-
ium perfringens ATCC® 13124™ [49] strains, were 
obtained from the AFBI laboratory collection. C. jejuni 
RC039 was grown on Blood Agar Base No. 2 (Oxoid Ltd., 
United Kingdom) supplemented with 5% (vol/vol) defi-
brinated horse blood (Aquilant Scientific N.I.). S. Typh-
imurium SE10/72 was resuscitated by adding one bead to 
tryptone soy broth (Oxoid, Basingstoke, UK) plus 0·6% 
(w/v) yeast extract (Oxoid) and incubating at 37  °C for 
24 h. Working cultures were maintained on TSAYE slants 
at 4  °C. Working cultures were prepared by inoculation 
of MHB with a loopful of culture from a slope and incu-
bating at 37  °C, for another 24 h. C. perfringens ATCC® 
13124™ was similarly resuscitated into anoxic Müeller 
Hinton broth (MHB) and then incubated anaerobically 
at 37  °C for 24 h. Working cultures were maintained on 
cooked meat medium at 4  °C for 30 days. Working cul-
tures were prepared by inoculation of MHB with 20  μl 
of overnight culture grown anaerobically at 37  °C in a 
cooked meat medium. To create anaerobic conditions, 
Anaerogen™ (Thermo Scientific™ Oxoid™) sachets were 
added to the 2.5 litter jar specified to maintain anaerobio-
sis. Thorough all experimental procedures, the C. perfrin-
gens ATCC® 13124™ strain was maintained and grown 
under anoxic environmental condition. The antimicro-
bial mixture, Auraguard, contained: 5% maltodextrin, 
1% sodium chloride, 42% citric acid, 18% sodium citrate, 
10% silica, 12% malic acid, 9% citrus extract and 3% olive 
extract (w/w). The raw materials were supplied by Biosci-
ence Nutrition Ireland.
Disc diffusion assay
Briefly, 100  μl of S. Typhimurium and C. perfringens 
bacterial cultures were spread onto Tryptone Soya Agar 
plus yeast extract (TSAYE Oxoid, UK), and C. jejuni 
was plated on Blood Agar Base Nr. 2 (BAB, Oxoid Ltd., 
United Kingdom) enriched with 5% (vol/vol) defibrinated 
horse blood (Aquilant Scientific N.I.). Next, the antimi-
crobial product was diluted in tenfold increments from 
100% to 0.078% (v/v) in MHB and 20 μl of correspond-
ing antimicrobial concentration was absorbed on 6  mm 
paper discs (Oxoid, UK). Antimicrobial activity of each 
antimicrobial was evaluated by the disc diffusion method 
according to the measuring of the diameter of the inhibi-
tion zone around the disc for each of antimicrobial con-
centrations used.
Determination of minimum inhibitory and minimum 
bactericidal concentration
The two-fold tube dilution method was used to deter-
mine the lowest concentration of Auraguard that inhib-
ited bacterial growth (MIC) and the lowest concentration 
that induced bacterial death (MBC) was evaluated [50]. 
Auraguard was diluted (8% to 0.015625% v/v) in Müeller 
Hinton broth (MHB) and thoroughly vortexed. Individual 
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overnight bacterial cultures were harvested by cen-
trifugation, washed twice in PBS, resuspended in MHB, 
and diluted to 1 ×  106  CFU/ml in MHB. Each tube was 
inoculated with 5 ×  105 CFU/ml of each bacterial culture 
(final concentration). Non-inoculated bijou (5 ml) tubes 
containing the same growth medium were used as nega-
tive controls, whilst MHB tubes without Auraguard were 
inoculated with individual bacterial cultures as positive 
controls. Subsequently, C. jejuni tubes were incubated at 
41.5 °C for 48 h, and C. perfringens and S. Typhimurium 
cultures were incubated at 37 °C for 24 h. Tubes that did 
not show visible growth were considered to be above the 
MIC. One hundred millilitres were taken from each tube 
for inoculation and then incubated at 37 °C for 24 h onto 
TSAYE on Campylobacter Blood-Free Selective Agar 
Base (Modified CCDA—Preston; Oxoid Ltd., United 
Kingdom) under microaerophilic at 41.5 °C for 48 h. The 
highest dilution of each antimicrobial with no microbial 
growth was considered as the MBC [51]. The antimicro-
bial mixture was tested using concentrations from 8 to 
0.0078% (v/v) in three independent replicates repeated 
three times for each strain. In order to determine the sub-
inhibitory concentrations used, all three pathogens were 
exposed to different concentrations of the antimicrobial 
mixture. The highest concentrations of antimicrobial that 
showed no effect on survivability and no growth inhibi-
tion (same growth kinetics as the control) were used in 
subsequent experiments [15].
Infectivity assays
The ECACC Madin–Darby Canine Kidney cells (MDCK) 
were grown in DMEM (Lonza, Analab Ltd., United King-
dom) supplemented with 10% foetal bovine serum. The 
cells were routinely grown in  75cm2 tissue culture flasks 
(Sigma-Aldrich, Arklow, Ireland, SIAL0641) in a humidi-
fied incubator at 37  °C with 5% CO2. The gentamicin 
protection assay was used to test the role of Auraguard 
towards the ability of C. jejuni RC039, S. Typhimurium 
SE 10/72 and C. perfringens ATCC® 13124™ to adhere 
to and invade host epithelial cells as previously explained 
[52]. MDCK cells were grown (80–90% confluence) for 
22–24 h in six-well tissue culture plates at a concentra-
tion of 5.5 ×  105 cells per well. The MDCK cell monolay-
ers were pre-incubated with 0.25 and 0.5% Auraguard 
for 2–3 h. The pH during all the experimental infections 
studies was maintained at neutral values (pH 7.2). Plate 
grown cultures of C. jejuni RC039, S. Typhimurium SE 
10/72 and C. perfringens ATCC® 13124™ were harvested, 
washed, and re-suspended in tissue culture medium at 
an OD600 of ≈ 0.3. The MDCK cells were washed twice 
with fresh culture media supplemented with 10% FBS, 
and 2 ml of fresh culture medium was added to each well. 
Bacteria were added to give a multiplicity of infection of 
100. Then, tissue culture plates were centrifuged at 250×g 
for 5 min, and the plates with Campylobacter were incu-
bated for 3 h at 41.5 °C in 85%  N2, 5%  O2 and 10%  CO2. 
Simultaneously, the six-well plates with Salmonella and 
Clostridia added for infection assays were subjected to 
37 °C incubation for 2 h. To quantify the number of cell-
associated bacteria, infected monolayers were washed 
three times with PBS and treated with 0.1% Triton X-100 
in PBS at 41.5 °C and 37 °C for 15 min. Ten-fold dilutions 
from each well were plated onto CCDA, and TSAYE agar 
(depending on bacteria culture) and the colonies were 
enumerated after 2 days of incubation at 41.5  °C in 85% 
 N2, 5%  O2, and 10%  CO2 or at 37 °C respectively. In order 
to inhibit the ERK signal transduction pathway 30 µM of 
PD98059 (Sigma-Aldrich, UK) was added to the infection 
plate 60  min prior to infection. The infected monolay-
ers were washed with tissue culture medium to quantify 
the number of bacteria that invaded MDCK cells. Fresh 
medium (2  ml) containing gentamicin (400  μg/ml) was 
added to kill bacteria that were not internalized. Medium 
without gentamicin was introduced to quantify the num-
ber of bacteria that adhered to the epithelial cells. Next, 
the tissue culture plates were incubated for a further 3 h 
at 41.5 °C or 37 °C and washed with fresh DMEM + 10% 
FBS. MDCK cells were lysed by the addition of 1  ml of 
0.1% Triton X-100 in PBS and incubated for 15  min at 
41.5  °C or 37  °C. Tenfold dilution of each well content 
was plated onto CCDA and TSAYE agar, and colonies 
were enumerated after 1–2 days of incubation. Invasion 
efficiency was calculated as the percentage of the total 
number of CFU/total initial inoculum. All assays were 
conducted in triplicate on three separate days. The sig-
nificance of differences in adhesion and invasion between 
samples was determined using the Student’s t-test. A 
p-value of < 0.05 was defined as significant.
Transepithelial electrical resistance (TEER) and paracellular 
permeability measurements
MDCK cells were plated onto transwells (5 ×  104; 6.5 mm 
diameter; 0.4  μm—pore size; Corning) and grown until 
apical junctional complexes developed. Transwells were 
infected apically with either C. jejuni RC039, S. enterica 
SE 10/72 or C. perfringens ATCC® 13124™. TEER was 
measured at 3 h after infection using an EVOM X meter 
connected to an Endohm chamber (World Precision 
Instruments). The paracellular permeability of MDCK 
cells was determined using calcein as the solute as 
described previously [53]. Flux assay data are presented 
as means (SD) of triplicate independent samples per-
formed three separate times. The presented results are 
representative of at least three independent experiments. 
The mean (SD) of at least three independent experiments 
for each cell line was calculated.
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Gene expression analysis
The quantification of zonula occludens-1 (ZO-1) and 
occluding expression was performed as previously 
described with small modifications [26]. Briefly, the 
exposed or infected MDCK cells were snap-frozen in 
liquid nitrogen until use. RNA was isolated using RNe-
asy Plus Mini Kit (Qiagen, United Kingdom). The RNA 
was reverse transcribed using Transcriptor First Strand 
cDNA Synthesis Kit (Roche) according to the manufac-
turer’s protocol. The mRNA levels were determined by 
quantitative RT-PCR using QuantiNovaSYBR Green 
PCR Kit (Qiagen, United Kingdom) on a LightCycler 96 
(Roche). The primers used for ZO-1 were F: CGG GAC 
TGT TGG TAT TGG CTAGA and R: GGC CAG GGC CAT 
AGT AAA GTTTG. For the occluding gene the primers 
used were F: TCC TAT AAA TCC ACG CCG GTTC and R: 
CTC AAA GTT ACC ACC GCT GCTG. The gene expres-
sion was normalized using the ribosomal protein lateral 
stalk subunit P0 (RPLP0) and glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH). The 2–DDCT method 
was used to analyse the relative expression (fold changes), 
calculated relative to the control group. In order to test 
the anti-inflammatory after LPS or Auraguard treat-
ment we evaluated the expression of the following genes: 
IL-1β, IL-6, IL-8, and TNF-α. The expression of GAPDH 
gene was used as a control. The primers used were: for 
IL1-β F-TGC AAA ACA GAT GCG GAT AA, and R-GTA 
ACT TGC AGT CCA CCG ATT; IL-6, F-TCC AGA ACA 
ACT ATG AGG GTGA, R-TCC TGA TTC TTT ACC TTG 
CTCTT; IL-8, F-TGA TTG ACA GTG GCC CAC ATT GTG , 
R-GTC CAG GCA CAC CTC ATT TC; TNF-α, F-CGT CCA 
TTC TTG CCC AAA C, R-AGC CCT GAG CCC TTA ATT 
C and for GADPH, F-TTC CAC GGC ACA GTC AAG , 
R-ACT CAG CAC CAG CAT CAC . The relative expression 
of the selected genes was calculated using the formula 
2-DDCt with DCt values being represented as means of 
three test replicates [54].
Intra and extracellular hydrogen peroxide  (H2O2) 
measurements in infected MDCK cells
Hydrogen peroxide  (H2O2) production was measured 
using a Hydrogen Peroxide Detection Kit (Enzo Life 
Sciences) or Amplex® UltraRed /HRP (Thermo Fischer 
Scientific, UK) according to the manufacturers’ instruc-
tions. Briefly, the lysis buffer or culture media (50  ml) 
were mixed with the Amplex® UltraRed /HRP (Thermo 
Fischer Scientific, UK) reagent and with the horseradish 
peroxidase resulting in a red fluorescent oxidation prod-
uct. Fluorescence was determined at 530  nm excitation 
and 590  nm emission using a fluorescence microplate 
reader (FLUOstar Omega, BMG Labtech). The concen-
trations of  H2O2 were calculated using standard curves. 
For intracellular measurements, after treatment with 
Auraguard the confluent cells were washed with phenol 
red free DMEM and incubated in the dark for 10  min 
in Krebs–Ringer solution containing 2′,7′-dichlorofluo-
rescin diacetate (DCF-DA; Sigma Aldrich, UK). Cell cul-
tures treated with diatrizoate (6%) or ioxag- late (10%) 
were detached from culture flasks, counted (1 ×  106 cells), 
and re-suspended in 800 μl of PBS. A solution of DCFH 
(200  μl) at final concentration 20  μmol/ml were added 
to the samples and incubated with agitation at 37 °C for 
30  min. The cells were centrifuged, resus- pended in 
EDTA, and carried out for fluorescence activated cell 
sorting (FACS) analysis. The values were averaged to 
obtain the mean relative fluorescence intensity, and the 
means were compared with each well. All experiments 
were repeated three times.
Western blotting
The infected cells, treated or un-treated with Auraguard, 
were boiled with SDS-PAGE loading buffer. Protein sam-
ples (40  μg) were subjected to SDS-PAGE and further 
transferred on nitrocellulose membranes. The mem-
branes were blocked with 5% dried milk in Tris-buffered 
saline and Tween-20 (TBST, 20 mM Tris-HCl, 150 mM 
NaCl, 0.05% Tween-20) for 6  h at room temperature. 
After washed with TBST, incubating the membranes in 
respective primary antibody solution (anti-phospho-ERK 
and anti-β-actin antibody, from Santa Cruz Biotech-
nology) overnight at 4˚C. After extensive washing, the 
membranes were then incubated with HRP-conjugated 
secondary antibody solution for 1 h at room temperature. 
The membranes were washed three times with TBST 
and the blots were detected by using enhanced chemilu-
minescence reagent (ECL) and exposed to photographic 
films (Kodak, Thermo Fischer, UK). Images were col-
lected and the bands corresponding to phospho-ERK 
protein were quantitated by densitometric analysis using 
the E-Gel Imager from Life Technologies. Data of phos-
pho-ERK were normalized on the basis of β-actin levels.
Measurement of tetrathionate production
MDCK cells were plated onto transwells (5 ×  104; 6.5 mm 
diameter; 0.4 –pore size; Corning). Transwells were 
infected apically with either C. jejuni RC039, S. enterica 
SE 10/72 or C. perfringens ATCC® 13124™. The cells 
were infected as described above. Sodium thiosulfate 
was added in each infection transwell, 60 min after infec-
tion, at a concentration of 10  mM. For measurements 
of tetrathionate produced by MDCK cells infected or 
infected in the presence of Auraguard (0.25 for C. jejuni 
and 0.50% for S. enterica and C. perfringens) Dimethylsul-
foxide or Phorbol 12-myristate 13-acetate (in Dimethyl-
sulfoxide) was added to tissue culture media at a final 
concentration of 1% and 10 µg/ml, respectively, and the 
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cells were incubated for 3 h at 37 °C 5%  CO2. All samples 
were filter sterilized, and analysed using ion pairing RP-
LC-MS as previously described [44, 55].
Statistical analysis
Statistical analyses were performed using GraphPad 
software. Data were represented as mean ± SD. p-val-
ues < 0.05 were considered statistically significant follow-
ing estimations using the Student t was used.
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